A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Leishmania Antibody (IgG)
Test Code92480
Alias/See Also
LAB1248
KALAZAR
VISCERAL LEISHMANIASIS
KALAZAR
VISCERAL LEISHMANIASIS
CPT Codes
86717
Preferred Specimen
0.2 mL serum
Minimum Volume
0.1 mL
Transport Container
Transport tube
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Grossly lipemic
Methodology
Enzyme Immunoassay (EIA)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Wed
Report Available
1-7 days
Reference Range
<1.00
Interpretive Criteria
This assay is intended to aid in the diagnosis of visceral leishmaniasis. Its use in diagnosing cutaneous leishmaniasis is limited, since a detectable antibody response is often absent in this form of the disease. Sera from patients with Chagas' disease (Trypanosoma cruzi infection) may be positive in this assay; thus, results should be used in conjunction with other clinical findings when considering a diagnosis of leishmaniasis.
Interpretive Criteria
<1.00 | Negative |
≥1.00 | Positive |
Clinical Significance
Detection of Leishmania IgG provides strong support for the diagnosis of visceral leishmaniasis. Some (but not all) patients with cutaneous leishmaniasis also have detectable serum levels of Leishmania IgG. Sera from patients with Trypanosoma cruzi infection (Chagas' disease) show significant cross-reactivity in the Leishmania IgG assay.
Performing Laboratory
Quest Diagnostics Nichols Institute-San Juan Capistrano, CA |
33608 Ortega Highway |
San Juan Capistrano, CA 92675-2042 |